This unique test analyses a specific group of genes that are known to be involved in drug metabolism for a broad range of medications used in the treatment of mental health conditions. The Neuropharmagen® report provides detailed interpretation and prescribing recommendations for many antidepressants, antipsychotics, anxiolytics/hypnotics ADHD medications and stabilizers and anticonvulsants.
Add to cart
Fragile X syndrome is a genetic condition that can cause a range of learning and developmental problems. These can include: intellectual disability hyperactivity or attention deficit disorder (ADD) anxiety autism spectrum disorder seizures hypotonia Some children with fragile X may also have mildly characteristic features such as prominent ears. Fragile X is more common in […]
Add to cart
Mitochondrial disorders, including Leber Hereditary Neuropathy (LHON) and Mitochondrial Encephalomyopathies (MELAS, MERRF and NARP) are detected with massively parallel, next generation sequencing of the Mitochondrial DNA. Although DNA-based testing provides highly accurate genotyping, rare diagnostic errors may occur. Examples include misinterpretation because of polymorphisms or rare genetic variants, blood transfusion, mislabeled specimens or erroneous representation […]